Literature DB >> 1422971

Alterations of the mineralization profile and osteocalcin concentrations in osteoarthritic cortical iliac crest bone.

G Raymaekers1, J Aerssens, R Van den Eynde, J Peeters, P Geusens, P Devos, J Dequeker.   

Abstract

The relation between bone mineralization and osteocalcin content was investigated in iliac crest cortical bone obtained at necropsy in young females and in two groups of elderly women with and without osteoarthritis of the hands evaluated by X-ray. Using density fractionation technique, the bone was separated into fractions of increasing density from 1.72 to 2.30 g/ml. The mineralization profile revealed a significant shift to higher densities in the osteoarthritis cases compared with young adults (P less than 0.005) and age-sex-matched controls (P less than 0.001). The ash, calcium, and phosphorus content of the bone increased with increasing density of the fractions whereas collagen content, measured as hydroxyproline, decreased. The osteocalcin concentration of each fraction was determined in the supernatants obtained after EDTA-extraction in the presence of protease inhibitors. In the young control and osteoarthritis group, the osteocalcin content in the lowest density fractions was higher compared with the older non-osteoarthritic group. Osteocalcin content of the high density fractions, representing highly mineralized osteons, was the same in the three groups studied. These findings support the hypothesis that quality differences in bone may explain the inverse relationship between osteoarthritis and osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422971     DOI: 10.1007/bf00334486

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  27 in total

1.  Modifications of a specific assay for hydroxyproline in urine.

Authors:  K I Kivirikko; O Laitinen; D J Prockop
Journal:  Anal Biochem       Date:  1967-05       Impact factor: 3.365

2.  Changes in quality of bone mineral on aging and in disease.

Authors:  M D Grynpas; D Holmyard
Journal:  Scanning Microsc       Date:  1988-06

3.  The protein in the matrix of bone.

Authors:  B Nusgens; A Chantraine; C M Lapiere
Journal:  Clin Orthop Relat Res       Date:  1972       Impact factor: 4.176

Review 4.  The relationship between osteoporosis and osteoarthritis.

Authors:  J Dequeker
Journal:  Clin Rheum Dis       Date:  1985-08

5.  Physical and histomorphological characteristics of iliac crest bone differ according to the grade of osteoarthritis at the hand.

Authors:  G Gevers; J Dequeker; P Geusens; C Nyssen-Behets; A Dhem
Journal:  Bone       Date:  1989       Impact factor: 4.398

6.  Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein.

Authors:  P D Delmas; H W Wahner; K G Mann; B L Riggs
Journal:  J Lab Clin Med       Date:  1983-10

7.  Concentrations of osteocalcin and phosphoprotein as a function of mineral content and age in cortical bone.

Authors:  J B Lian; A H Roufosse; B Reit; M J Glimcher
Journal:  Calcif Tissue Int       Date:  1982       Impact factor: 4.333

8.  Changes with age in the non-collagenous proteins of human bone.

Authors:  I R Dickson; M K Bagga
Journal:  Connect Tissue Res       Date:  1985       Impact factor: 3.417

9.  Biomechanical characteristics of iliac crest bone in elderly women according to osteoarthritis grade at the hand joints.

Authors:  G Gevers; J Dequeker; M Martens; R Van Audekercke; C Nyssen-Behets; A Dhem
Journal:  J Rheumatol       Date:  1989-05       Impact factor: 4.666

10.  Alterations of the gamma-carboxyglutamic acid and osteocalcin concentrations in vitamin D-deficient chick bone.

Authors:  J B Lian; M J Glimcher; A H Roufosse; P V Hauschka; P M Gallop; L Cohen-Solal; B Reit
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

View more
  8 in total

1.  Lack of in vitro evidence for storage of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 1,25(OH)2D3 binding protein in skeletal matrix.

Authors:  S Boonen; J Aerssens; I Jans; E Van Herck; I Vandewal; J Peeters; R Van den Eynde; J Dequeker; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

2.  Thermal stability and structure of cancellous bone mineral from the femoral head of patients with osteoarthritis or osteoporosis.

Authors:  L D Mkukuma; C T Imrie; J M S Skakle; D W L Hukins; R M Aspden
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

3.  Bone mineral density and bone turnover in spinal osteoarthritis.

Authors:  J Dequeker; J M Mbuyi-Muamba
Journal:  Ann Rheum Dis       Date:  1996-05       Impact factor: 19.103

4.  Bone mineral density and osteoarthritis.

Authors:  J Dequeker; J Aerssens
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

5.  Osteocalcin synthesis by human osteoblasts from normal and osteoarthritic bone after vitamin D3 stimulation.

Authors:  Francesco Paolo Cantatore; Addolorata Corrado; Maria Grano; Laura Quarta; Silvia Colucci; Nadia Melillo
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

6.  The relationship between osteoarthritis of the hands, bone mineral density, and osteoporotic fractures in elderly women.

Authors:  C Marcelli; F Favier; P O Kotzki; V Ferrazzi; M C Picot; L Simon
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

7.  The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein.

Authors:  Kelitha Maxis; Aline Delalandre; Johanne Martel-Pelletier; Jean-Pierre Pelletier; Nicolas Duval; Daniel Lajeunesse
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

8.  Differential gene expression of bone anabolic factors and trabecular bone architectural changes in the proximal femoral shaft of primary hip osteoarthritis patients.

Authors:  Le-Hoa Truong; Julia S Kuliwaba; Helen Tsangari; Nicola L Fazzalari
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.